Correlation Between Vitrolife and Surgical Science

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vitrolife and Surgical Science at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vitrolife and Surgical Science into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vitrolife AB and Surgical Science Sweden, you can compare the effects of market volatilities on Vitrolife and Surgical Science and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vitrolife with a short position of Surgical Science. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vitrolife and Surgical Science.

Diversification Opportunities for Vitrolife and Surgical Science

-0.56
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Vitrolife and Surgical is -0.56. Overlapping area represents the amount of risk that can be diversified away by holding Vitrolife AB and Surgical Science Sweden in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Surgical Science Sweden and Vitrolife is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vitrolife AB are associated (or correlated) with Surgical Science. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Surgical Science Sweden has no effect on the direction of Vitrolife i.e., Vitrolife and Surgical Science go up and down completely randomly.

Pair Corralation between Vitrolife and Surgical Science

Assuming the 90 days trading horizon Vitrolife is expected to generate 2.57 times less return on investment than Surgical Science. But when comparing it to its historical volatility, Vitrolife AB is 1.18 times less risky than Surgical Science. It trades about 0.01 of its potential returns per unit of risk. Surgical Science Sweden is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  15,281  in Surgical Science Sweden on November 5, 2024 and sell it today you would earn a total of  2,009  from holding Surgical Science Sweden or generate 13.15% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

Vitrolife AB  vs.  Surgical Science Sweden

 Performance 
       Timeline  
Vitrolife AB 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Vitrolife AB has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of comparatively stable basic indicators, Vitrolife is not utilizing all of its potentials. The current stock price uproar, may contribute to short-horizon losses for the private investors.
Surgical Science Sweden 

Risk-Adjusted Performance

12 of 100

 
Weak
 
Strong
Good
Compared to the overall equity markets, risk-adjusted returns on investments in Surgical Science Sweden are ranked lower than 12 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain basic indicators, Surgical Science unveiled solid returns over the last few months and may actually be approaching a breakup point.

Vitrolife and Surgical Science Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vitrolife and Surgical Science

The main advantage of trading using opposite Vitrolife and Surgical Science positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vitrolife position performs unexpectedly, Surgical Science can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Surgical Science will offset losses from the drop in Surgical Science's long position.
The idea behind Vitrolife AB and Surgical Science Sweden pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Other Complementary Tools

Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Fundamental Analysis
View fundamental data based on most recent published financial statements
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios